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Abstract
Noroviruses are the most frequent cause of acute gastroenteritis in the community. In Catalonia, it is not clear how this type of viral
gastroenteritis is evolving, and the objective of this prospective population-based study was to describe the incidence and epidemiologi-
cal and clinical features of outbreaks of acute gastroenteritis due to norovirus in Catalonia between October 2004 and October 2005.
Incidence rates were calculated using the estimated population of Catalonia in 2005. For each outbreak, the mode of transmission, the
number of persons affected, demographic variables, clinical presentation, the date and time of onset of symptoms and the duration of
symptoms, physician visits and hospitalizations were collected. Sixty viral outbreaks affecting 1791 people were identiﬁed, with no
distinct seasonality. The mean number of outbreaks per month was 4.6. The global incidence was 24.6 per 100 000 person-years. The
incidence was higher in women (25.7 per 100 000 person-years) and in the 5–11 years (52.4 per 100 000 person-years) and ‡65 years
(42.4 per 100 000 person-years) age groups. The prevalence of vomiting, abdominal pain and general malaise was higher in children and
adolescents, whereas the prevalence of diarrhoea and myalgia was higher in adults. These results suggest that norovirus infection has an
important public health impact in Catalonia and that prevention strategies should be designed and implemented.
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Introduction
Gastrointestinal tract infections are common in both devel-
oping and developed countries [1] and are produced by a
wide variety of enteropathogens including bacteria, viruses
and parasites. The main causes of viral gastroenteritis include
adenoviruses, astroviruses, noroviruses (NV) and rotaviruses
[2]. Since the original outbreak of Norwalk virus gastroen-
teritis in an elementary school in Norwalk (OH, USA) in the
fall of 1968, studies have shown that viral infections, espe-
cially those due to NV, are the most frequent cause of acute
gastroenteritis in the community [3–7]. NV infects all age
groups, with particularly severe disease occurring in young
children, the elderly, and persons with chronic illness [8].
NV infections have historically been described as mild and
self-limiting. Studies in the 1970s were the basis for the cri-
teria used by Kaplan et al. to discern outbreaks with a viral
aetiology, which include stool culture negative for bacterial
pathogens, mean (or median) duration of illness 12–60 h,
vomiting in ‡50% of cases, and, if known, mean (or median)
incubation period of 24–48 h [9].
NV have emerged as an important cause of human viral
gastroenteritis and cause outbreaks in a wide range of set-
tings, including nursing homes, hospitals, retirement centres,
summer camps, schools, restaurants and events with catered
meals and cruise ships. The mode of transmission may be
foodborne, waterborne or person-to-person contact [9–12].
There are many reports of NV outbreaks that include
details on the mode of transmission and setting and, in some
cases, the molecular epidemiology of circulating NV strains [3–
5,7,9,13–16]. However, there are fewer reports on the clinical
manifestations of NV infections in the community [11,17].
The objective of this study was to describe the epidemiolog-
ical and clinical features of outbreaks of acute gastroenteritis
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due to NV in Catalonia between October 2004 and October
2005.
Materials and Methods
In Catalonia, a region of seven million inhabitants in
the northeast of Spain, reporting of epidemic outbreaks of
gastroenteritis by public and private physicians to the
Department of Health is mandatory.
Between 15 October 2004 and 30 October 2005, infor-
mation on all reported viral outbreaks of gastroenteritis
was systematically compiled and epidemiological and clinical
data of cases involved in the outbreaks were collected on a
standardized form using a protocol designed speciﬁcally for
the study. For each outbreak, the mode of transmission,
the number of persons affected, the age and sex, clinical
presentation (including diarrhoea, vomiting, abdominal pain,
nausea, fever, headache, myalgia, general malaise and chills),
the date and time of onset of symptoms and the duration
of symptoms, physician visits and hospitalizations were
collected.
The case deﬁnition of viral gastroenteritis used was two
or more loose stools in 24 h and/or vomiting twice or
more in 24 h, with additional symptoms including nausea,
fever, abdominal pain, headache, myalgia, general malaise
and chills.
The incidence rates of cases associated with outbreaks
occurring during the study period were calculated using the
estimated population of Catalonia in 2005 and the 95% CIs
were calculated assuming Poisson distribution.
Stool samples were collected using the following norms:
(i) samples were collected during the acute phase (ﬁrst
3–5 days) of the infection; (ii) a minimum of 1 g of faeces
was collected in a sterile, preferably plastic, container; (iii)
no faeces mixed with urine were collected; (iv) only faeces
without preservative were collected; and (v) no samples
were collected using rectal swabs. Samples were kept at
room temperature for 2 h followed by refrigeration at 4C
for 2 days and freezing at )20C until microbiological analy-
sis, which was carried out by the reference laboratories.
Samples were transported to the laboratory in a refrigerated
state by courier. Samples were pre-screened using standard
microbiological tests to rule out bacteria and parasites.
Viruses were identiﬁed by RT-PCR according to previously
described methods [18–20].
In the statistical analysis, the v2 test was used to measure
qualitative variables and Student’s t-test to measure quantita-
tive variables. All statistical analyses were carried out using
the SPSS V12 statistical program (SPSS Inc., Chicago, IL, USA).
The level of statistical signiﬁcance was established as
a = 0.05.
Results
During the study period, 60 viral outbreaks affecting 1791
people were identiﬁed. The outbreaks occurred mainly in
restaurants (37%), nursing homes (18.3%), private residences
(18.3%), hospital or long-term care facilities (10%), and holi-
day camps (10%). Incidence rates were calculated using the
1791 cases identiﬁed.
Two hundred and forty-seven cases were excluded from
the analysis of the onset of symptoms, disease duration and
symptoms presented due to lack of information on these
variables. Therefore the remaining analyses were made in
1544 cases. Stool samples were analysed in 534 patients. In
six patients infected by norovirus, co-infection by Salmonella
typhimurium or Vibrio parahaemolyticus was detected. Viruses
were found in 277 patients, of which 273 corresponded to
NV. The genotype was determined in 217/273 samples
positive for NV. Because the samples were pre-screened
using standard microbiological tests to rule out bacteria and
parasites, these enteropathogens were not determined in
our investigation.
The outbreaks occurred predominantly between October
and March (excepting January) with an increase from July
onwards, although outbreaks occurred during all the months
studied (Fig. 1). The mean number of outbreaks per month
was 4.6 (SD ± 2.2).
The global incidence rate was 24.6/100 000 person-years
(95% CI 23.4–25.7), with rates of 25.7/100 000 person-years
in women and 18.2/100 000 person-years in men. The inci-
dence rates were highest in the 5–11 years and ‡65 years
age groups (Table 1).
Persons of all ages, from 14 months to 100 years, were
affected (mean age 44.7 years). A total of 24.1% of cases
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FIG. 1. Monthly distribution of the 60 outbreaks included in the
study. N.B. When setting ﬁgure, use the powerpoint version, which
has the axes correctly labelled.
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‡15 years age group (15–64 years, 42.8%; ‡65 years, 33.1%).
Forty-one percent of cases occurred in male subjects (mean
age 38.6 years, SD ± 27.8) and 59% in female subjects (mean
age 49.1 years, SD ± 30.1) (p <0.001), of which 30.4%
occurred in male subjects aged <15 years, compared with
19.7% in female subjects (p <0.001).
The ﬁrst symptom to appear was diarrhoea in 23.1% of
cases, vomiting in 19.6% and abdominal pain in 15.9%. Diar-
rhoea and vomiting coexisted in 45.2% of cases, and there
was diarrhoea without vomiting in 34.9% of cases and vomit-
ing without diarrhoea in 19.9%.
The mean number of defaecations in 24 h was 4.5
(SD ± 3.5); the mean number of episodes of vomiting in
24 h was 3.7 (SD ± 2.5); in patients with fever, the mean
maximum temperature was 37.8C (SD ± 0.6C).
Abdominal pain and fever were more frequent in men
than in women (70.8% vs. 64.4%, p 0.013; and 34.5% vs.
28.9%, p 0.022, respectively). No differences were found
between sexes for the other symptoms studied (Table 2).
Diarrhoea occurred more frequently in people aged
>18 years, whereas vomiting and abdominal pain were more
frequent in people aged <18 years (Table 3). Malaise was
more frequent in children aged <11 years. The other symp-
toms studied were more frequent in the 12–64 years age
group. In the ‡65 years age group, the predominant symp-
tom was diarrhoea (87.9%) followed by vomiting (52.9%).
The risk of diarrhoea was greater in people aged >65 than in
people aged <65 years (OR 2.61; 95% CI 1.93–3.55),
whereas the other clinical manifestations were associated
with age <65 years (Table 4).
Vomiting and abdominal pain were more frequent in chil-
dren aged <5 years (74.6% and 91.5%, respectively) com-
pared with people aged ‡5 years, although diarrhoea
presented practically equally in both groups (77.2% in people
aged <5 years and 78.5% in those aged ‡5 years). There was
a statistically signiﬁcant difference between the two age
groups with respect to abdominal pain, but not with respect
to diarrhoea and vomiting.
The mean disease duration was 49 h (SD ± 39.9 h, 80th
percentile, 3 days) and was longer in women than in men
(52 h vs. 46 h; p 0.016). The mean disease duration was 38 h
in the <5 years age group compared with 50 h in the
>5 years age group (p 0.093); 35 h in the <15 years age
group compared with 54 h in the >15 years age group
(p <0.001) and 45 h in the <65 years age group compared
with 57 h in the ‡65 years age group (p <0.001).
The norovirus genotype was sequenced in 63.3% of the
outbreaks, with both GI and GII strains being found. The
most frequently isolated genotype was GGII.4, followed by
GGII.2, GGIIb, GGI.1 and GGI.6. The GGII.4 genotype pre-
dominated in persons aged ‡15 years, the GGII.2 genotype
in persons aged <15 years and the GGI.6 genotype was iso-
lated only in persons aged <15 years.
Discussion
We studied the incidence rates and clinical and epidemiologi-
cal characteristics of cases of gastroenteritis associated with
community outbreaks of NV infection reported to the epide-
miological surveillance services in Catalonia. Isolated cases of
gastroenteritis due to NV and unreported outbreaks were
not included.
TABLE 1. Incidence rates and rates ratio of cases according
to age and sex
Incidence rates per
100 000 person-years
(95% CI) Rates ratio (95% CI)
Global 24.6 (23.4–25.7)
Sexa
Male 18.2 (16.8–19.6) Reference
Female 25.7 (24.1–27.3) 1.41 (1.28–1.56)
Ageb
<1 year No cases – –
1–4 years 20.6 (15.4–25.8) Reference 1.58 (1.22–2.06)
5–11 years 52.4 (45.8–59.0) 2.54 (1.92–3.37) 4.03 (3.48–4.68)
12–17 years 30.2 (24.8–35.6) 1.46 (1.08–2.00) 2.32 (1.91–2.82)
18–64 years 13.0 (12.0–14.0) 0.63 (0.48–0.82) Reference
‡65 years 42.4 (38.7–46.1) 2.06 (1.58–2.68) 3.26 (2.90–3.66)
Ageb
<1 year No cases – –
1–4 years 20.6 (15.4–25.8) Reference 1.79 (1.35–2.36)
5–14 years 50.1 (44.6–55.5) 2.43 (1.85–3.19) 4.34 (3.69–5.02)
15–24 years 18.1 (15.6–21.0) 0.88 (0.65–1.18) 1.57 (1.28–1.92)
25–39 years 12.9 (11.3–14.5) 0.63 (0.47–0.83) 1.12 (0.94–1.33)
40–64 years 11.5 (10.1–12.9) 0.56 (0.42–0.74) Reference
‡65 years 42.4 (38.7–46.1) 2.06 (1.58–2.68) 3.68 (3.17–4.27)
aIn 189/1791 cases, sex was unknown.
bIn 230/1791 cases, age was unknown.







OR (95% CI)Cases % Cases % Cases %
Diarrhoea 1186 78.8 483 78.4 703 79.0 0.96 (0.75–1.24)
Vomiting 964 64.9 390 64.0 574 65.5 0.94 (0.76–1.16)
Abdominal pain 945 67.0 402 70.8 543 64.4 1.34 (1.06–1.68)
Nausea 728 51.6 289 50.6 439 52.3 0.94 (0.76–1.16)
Fever 453 31.2 203 34.5 247 28.9 1.30 (1.04–1.63)
Headache 426 31.0 172 31.5 254 30.7 1.04 (0.82–1.31)
Myalgia 313 24.1 128 24.2 185 24.1 1.01 (0.78–1.30)
Chills 184 15.4 77 16.1 107 14.9 1.10 (0.80–1.51)
General malaise 117 7.6 56 8.8 61 6.7 1.35 (0.93–1.97)
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In addition, there may have been under-detection of cases
in outbreaks mainly due to non-detection of secondary cases;
this should be taken into account when interpreting the inci-
dence rates found, which undoubtedly underestimate the
magnitude of community NV infections. Mead et al. [21] used
a variety of sources to estimate that 23 million cases of NV
infection occur in the USA each year, a rate higher than
8000 cases/100 000 person-years.
Within the limited 12.5-month surveillance period, no
distinct seasonality of outbreaks was observed, in contrast to
longer studies [5,12,22], which found seasonal differences.
Some investigations where the study period of 12–18 months
was similar to ours [23,24] found that outbreaks appeared to
have winter–spring seasonality or that norovirus-associated
outbreaks showed a peak in the January–March period. Only
one 3-year study found no distinct seasonality of outbreaks
[25].
As in other studies, we found that NV infections occurred
in all age groups [6,11,26–28], with the highest incidence
rates occurring in the 5–14 years and ‡65 years age group.
Rockx et al. [11] found that 88% of cases occurred in
children aged <12 years compared with 18.9% in our study.
We found that 25.4% of cases occurred in people aged
70–90 years, compared with 60% in the study by Hedlund
et al. [22], although in this study 76% of outbreaks occurred
in general hospitals (median age 78 years) and nursing homes
(median age 84 years).
The mean age of cases in our study was 44.7 years, very
similar to that found by other investigators [22,23,25]. Fifty-
nine percent of cases occurred in women, similar to the
results found by Marshall et al. [24] and Fankhauser et al.
[25]. It has been suggested that hormonal factors could affect
the physiology of the digestive tract and favour infection in
women [29], but further research is needed to conﬁrm this.
In our study, the crude incidence rates show that no cases
occurred in infants aged <1 year and that the incidence was
20.6 cases/100 000 person-years in the 1–4 years age group,
substantially different from the crude incidence rates found in
two studies by Witt et al. [6,7], in which higher levels were
found in these age groups. There may be two reasons for this.
First, the studies by Witt et al. refer to gastroenteritis of any
aetiology, although NV represented 5% and 11%, respectively,
and it would be necessary to know the speciﬁc rates for NV
infection. Second, a possible limitation of our study could be
the underreporting of secondary cases, especially in infants
aged <1 year, who do not share adult meals and therefore
are not exposed to risk from collective catering or other
areas in which outbreaks are common in Catalonia [30].
The highest incidence rate was found in the 5–11 years
group (52.4 cases/100 000 person-years) and the lowest in
TABLE 3. Distribution of symptoms according to age group in 1544 cases
Symptoms
Age group
All casesa 1–4 years 5–11 years 12–17 years 18–64 years ‡65 years
Cases % Cases % Cases % Cases % Cases % Cases %
Diarrhoea 1150 78.4 44 77.2 108 49.8 57 53.8 504 85.6 437 87.9
Vomiting 940 65.1 44 74.6 180 82.2 91 84.3 369 64.2 256 52.9
Abdominal pain 922 67.2 54 91.5 180 86.1 73 83.0 416 74.4 199 43.5
Nausea 712 51.9 17 30.4 110 54.7 66 75.0 362 64.0 157 34.1
Fever 448 31.7 19 32.2 71 33.3 42 40.0 230 41.5 86 17.8
Headache 417 31.3 11 20.4 81 40.1 49 57.0 221 41.5 55 12.0
Myalgia 303 24.1 10 18.5 13 6.8 17 22.1 203 39.4 60 14.2
Chills 181 15.7 3 7.7 17 12.8 24 30.0 107 22.2 30 7.1
General malaise 117 7.8 10 16.7 45 20.1 5 4.5 44 7.2 13 2.6
aIn 40/1544 cases, age was unknown.
TABLE 4. Symptoms presented by
two different age groups
Symptoms








(%) OR (95% CI)
Diarrhoea 78.5 77.2 1.08 (0.57–2.03) 87.9 73.6 2.61 (1.93–3.55)
Vomiting 64.6 74.6 0.62 (0.34–1.13) 52.9 71.2 0.45 (0.36–0.57)
Abdominal pain 66.1 91.5 0.18 (0.07–0.45) 43.5 79.0 0.20 (0.16–0.26)
Nausea 52.8 30.4 2.57 (1.44–4.58) 34.1 60.9 0.33 (0.26–0.42)
Fever 31.7 32.2 0.98 (0.56–1.71) 17.8 38.9 0.34 (0.26–0.45)
Headache 31.7 20.4 1.82 (0.93–3.56) 12.0 41.4 0.19 (0.14–0.26)
Myalgia 24.3 18.5 1.41 (0.70–2.84) 14.2 29.1 0.40 (0.29–0.55)
Chills 15.9 7.7 2.27 (0.69–7.47) 7.1 20.5 0.30 (0.20–0.45)
General malaise 7.4 16.7 0.40 (0.20–0.81) 2.6 10.3 0.23 (0.13–0.42)
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the 18–64 years age group. In persons aged ‡65 years the
rates increased to 42.4 cases/100 000 person-years, a rise
not seen in the studies by Witt et al. [6,7].
The predominant clinical manifestations observed, as in
other studies [11,27,28,31], were diarrhoea, vomiting,
abdominal pain and nausea and, to a lesser extent, fever,
headache, myalgia, chills and general malaise. Children and
adolescents are likely to experience vomiting more fre-
quently than diarrhoea, whereas adults experience diarrhoea
more usually than vomiting. The prevalence of vomiting,
abdominal pain and general malaise was higher in children
and adolescents, whereas the prevalence of diarrhoea and
myalgia was higher in adults. Go¨tz et al. [27] also observed a
greater prevalence of diarrhoea and myalgia in adults and a
greater prevalence of vomiting in children; the main differ-
ence between the two studies was that we found a predomi-
nance of headache in children and not in adults. Rockx et al.
[11] found that diarrhoea was more frequent in patients aged
<5 years and vomiting and abdominal pain were most fre-
quent in patients aged >5 years, unlike our study, where the
frequency of diarrhoea was slightly greater in patients aged
‡5 years and the frequency of vomiting and abdominal pain
was greater in patients aged <5 years.
The mean disease duration was 49 h, much lower than
the mean of 5 days found by Rockx et al. [11] and compara-
ble to other studies where the disease duration ranged
between 12 and 60 h [31,32]. Like Rockx et al., we found
multiple circulation of NV genotypes, which were not associ-
ated with particular clinical manifestations. In conclusion, this
study presents the natural history, duration and symptoms of
NV infection in the community. Our results were fairly close
to the criteria of Kaplan et al. [9], with a high frequency of
vomiting, a short infection duration and stool cultures nega-
tive for bacterial pathogens.
However, one main difference with respect to the study
by Rockx et al. [11] was the disease duration, suggesting that
the burden of illness may be underestimated when ﬁndings
are based on historic data on the duration of illness. Our
prospective study detects this difference and more closely
resembles Kaplan’s criteria. However, like Rockx et al., we
also consider that community studies to evaluate the real
incidence of NV infections are essential to determinate the
characteristics of NV gastroenteritis.
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